Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Biosciences Plans Reverse Stock Split

NEW YORK (GenomeWeb) – Pressure Biosciences announced today that it plans to effect a reverse split of its common stock in order to satisfy the Nasdaq's requirements for initial listing on the exchange.

The one-for-30 reverse split, effective as of June 5, is intended to increase the per-share trading price of the company's common stock to satisfy the $4 minimum bid price requirement for initial listing on the Nasdaq. Every 30 shares of Pressure's common stock issued and outstanding prior to the opening of trading on June 5 will be consolidated into one issued and outstanding share.

The shares underlying the company's outstanding convertible securities will also be adjusted accordingly, Pressure said. Trading of the company's common stock on the OTCQB exchange will continue on a split-adjusted basis.

The company will have approximately 1.1 million shares issued and outstanding immediately after the reverse stock split goes into effect.

The Scan

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.